Production of aunp for in vivo analysis of BBB safety and integrity

Ended Purchase Order Awarded Last action

Contract number
75F40122P00454
Awardee
Awarding agency
Obligated
$25,025

Award facts

Contract value 100% obligated
$25,025.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20903, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Vendor DUNS or Name Change - Non-Novation P00001 $0
Original award $25,025

About this award

The Department of Health and Human Services Food and Drug Administration awarded a $25,025 firm fixed price purchase order to Nanocomposix, LLC for the production of amino-functionalized silica nanoparticles for in vivo analysis of blood-brain barrier safety and integrity. Performance will take place in Silver Spring, Maryland by September 15, 2023. No set-aside designation was applied to this contract for Nanocomposix to deliver amino-functionalized silica nanoparticles to the FDA, presumably in support of the agency's research evaluating new drug candidates and their potential effects on the blood-brain barrier.

Quick answers

Who was awarded contract 75F40122P00454?

75F40122P00454 was awarded to Nanocomposix, LLC by Food and Drug Administration (Department of Health and Human Services) on September 13, 2022.

How much is contract 75F40122P00454 worth?

The government has obligated $25,025 on 75F40122P00454.

Was contract 75F40122P00454 competed?

The extent of competition for 75F40122P00454 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award